| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/10/1997 | CA2233919A1 Unit galenical form for local hormonotherapy of vaginal dryness |
| 04/10/1997 | CA2233917A1 Therapeutic administration of hemoglobin in cardiac arrest |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2233606A1 Butyrate prodrugs of lactic acid |
| 04/10/1997 | CA2233544A1 Combination temozolomide and alpha-ifn for the treatment of advanced cancer |
| 04/10/1997 | CA2233296A1 Compound having sequence homology with lipoprotein associated phospholipase a2 (lp-pla2)/paf acetyl hydrolase |
| 04/10/1997 | CA2233003A1 Pyrimidine derivatives as 5ht2c-receptor antagonists |
| 04/10/1997 | CA2232990A1 Acridone derivatives |
| 04/10/1997 | CA2232865A1 The use of flt3 ligand to generate dendritic cells |
| 04/10/1997 | CA2232509A1 Tetrahydroquinolines as nmda antagonists |
| 04/10/1997 | CA2232134A1 Use of threonine for the treatment of phenylketonuria |
| 04/10/1997 | CA2231557A1 Compositions of melatonin and analgetic agents and methods of use thereof |
| 04/10/1997 | CA2231553A1 Use of carbohydrates for promoting skin exfoliation |
| 04/10/1997 | CA2231505A1 Preparation of glucosaminyl muramic acid derivatives |
| 04/10/1997 | CA2231500A1 Novel amino acid derivatives, their preparation and use |
| 04/10/1997 | CA2231073A1 Synthetic multivalent slex containing polylactosamines and methods for use |
| 04/10/1997 | CA2229785A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2228938A1 Treatment of atherosclerosis |
| 04/10/1997 | CA2226980A1 Purine and guanine derivatives |
| 04/10/1997 | CA2226958A1 Purine and guanine derivatives as pnp inhibitors |
| 04/10/1997 | CA2223004A1 Hair care composition including at least one silicone polymer grafted by anionic, amphoteric or non-ionic monomers, and at least one amphoteric polymer |
| 04/10/1997 | CA2206396A1 Process for producing n-(d-.alpha.-methyl-.beta.-mercaptopropionyl)-l-proline and intermediates thereof |
| 04/10/1997 | CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/09/1997 | EP0767174A1 Novel aminoalkanephosphinic acids and their salts |
| 04/09/1997 | EP0767172A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection |
| 04/09/1997 | EP0767170A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 04/09/1997 | EP0767167A1 Trifluoromethylsulfonylphenyl or trifluoromethylsulfinylphenyl group containing 2-cyano-3-hydroxy-propenamide derivatives, process for their preparation, their use as medicaments and pharmaceutical compositions containing them |
| 04/09/1997 | EP0766966A2 Method of treating insulin resistance |
| 04/09/1997 | EP0766964A1 Use of orotic acid for the preparation of a medicament for protection of membranes and endothel |
| 04/09/1997 | EP0766963A1 Arteriosclerosis depressant |
| 04/09/1997 | EP0766962A2 Treatment of atherosclerosis |
| 04/09/1997 | EP0766961A1 Use of gamma-linolenic acid or dihomogammalinolenic acid for the manufacture of a medicament for the treatment of Huntington's Chorea |
| 04/09/1997 | EP0766960A1 External preparations for treating dermatoses |
| 04/09/1997 | EP0766959A1 Cosmetic sunscreening compositions containing TiO2 nanopigments and an acrylaminoacid |
| 04/09/1997 | EP0766699A1 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
| 04/09/1997 | EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 04/09/1997 | EP0766691A1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
| 04/09/1997 | EP0766689A1 Novel oligosaccharide derivatives, preparation method therefor and uses thereof |
| 04/09/1997 | EP0766688A1 Synthesis of oligonucleotides |
| 04/09/1997 | EP0766687A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
| 04/09/1997 | EP0766685A1 Aryl, alkyl, alkenyl, and alkynylmacrolides |
| 04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
| 04/09/1997 | EP0766683A1 Novel substituted purinyl derivatives with immunomodulating activity |
| 04/09/1997 | EP0766682A1 Protein kinase c inhibitors |
| 04/09/1997 | EP0766680A1 Substituted dihydrobenzofuran derivatives as 5-ht 4 agonists |
| 04/09/1997 | EP0766679A1 Bioactive acetogenins and derivatives |
| 04/09/1997 | EP0766676A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 04/09/1997 | EP0766674A1 New hiv protease inhibitors |
| 04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/09/1997 | EP0766670A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/09/1997 | EP0766669A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/09/1997 | EP0766668A1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 04/09/1997 | EP0766667A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 04/09/1997 | EP0766665A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766664A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766570A1 Methods for treating respiratory disease |
| 04/09/1997 | EP0766562A1 Therapeutical compositions comprising 3-phenyl-3-hydroxypiperidines |
| 04/09/1997 | EP0766561A1 Utilisation of derivatives of 1,2,5,6-tetrahydropyridine for the preparation of sedative medicaments |
| 04/09/1997 | EP0766559A1 Cannabinoid receptor antagonists |
| 04/09/1997 | EP0766558A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 04/09/1997 | EP0766557A1 Topical compositions comprising n-acetyl-l-cysteine |
| 04/09/1997 | EP0766538A1 Subcutaneous implant |
| 04/09/1997 | EP0705263B1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 04/09/1997 | EP0675890B1 Condensed benzo(d)isoxazole derivatives and their use as psychoactive agents |
| 04/09/1997 | EP0664696B1 Sustained release compositions for treating periodontal disease |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 04/09/1997 | EP0630381B1 Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives |
| 04/09/1997 | EP0629202B1 Antiparasitic avermectin and milbemycin derivatives |
| 04/09/1997 | EP0625911B1 Malaria treatments |
| 04/09/1997 | EP0613481B1 Triamino platinum complexes and a method for the synthesis thereof |
| 04/09/1997 | EP0599890B1 Geneserine derivatives as cholinesterase inhibitors |
| 04/09/1997 | EP0588875B1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 04/09/1997 | EP0568574B1 Method of preparation of a pyrogen-free fructane which is readily soluble in water, and an agent containing such a fructane for the examination of kidney function |
| 04/09/1997 | EP0541737B1 N-phenyl-cinnamamides providing protection from the harmful effects of ultraviolet light |
| 04/09/1997 | EP0538305B1 Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections |
| 04/09/1997 | CN1147258A Process for preparation of 4-amino-'delta' 4-3-ketosteroids via 4-nitro-'delta'4-3-ketosteroids |
| 04/09/1997 | CN1147254A Prodrugs of morpholine tachykinin receptor antagonists |
| 04/09/1997 | CN1147253A Novel crystal forms of 1-[5-methanesulfonamido indolyl-2-carbonyl]-4-[3(1-methylethylamino)-2-pyridinyl] piperazine |
| 04/09/1997 | CN1147251A Tetrasubstd. imidazole derivs., method for preparing same, resulting intermediates, use thereof as drug, and pharmaceutical composition contg. same |
| 04/09/1997 | CN1147250A Naphthalene derivs. as prostaglandin I2 agonists |
| 04/09/1997 | CN1147208A Solvent extraction process |
| 04/09/1997 | CN1147205A Antithrombotic agents |
| 04/09/1997 | CN1147204A Use of spiramycin for treating |
| 04/09/1997 | CN1147203A Molten granulated sucralfate preparation and process for producing same |
| 04/09/1997 | CN1147202A Wet granulation formulation for bisphosphonic acids |
| 04/09/1997 | CN1147201A Halomethyl amides as IL-1 'beta' protease inhibitors |
| 04/09/1997 | CN1146992A Process for preparation of intermediate (R)-3-amino-5-methoxychroman |
| 04/09/1997 | CN1146991A Arylalkyl-thiadiazinones |
| 04/09/1997 | CN1146987A 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 04/09/1997 | CN1146915A Compound anticancer, its preparing process and use |
| 04/09/1997 | CN1146895A Use of bolbostemmaoside A to prepare medicine for treatment of leukemia |
| 04/09/1997 | CN1034504C Process for preparing thioalkylthio cephalosporin derivs. |
| 04/09/1997 | CN1034503C Pyrazolopyrimidinone antianginal agent preparing process |
| 04/09/1997 | CN1034502C Method for preparing N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H benzopyran or dihydrobenzodioxin) carboxamide derivs |
| 04/09/1997 | CN1034501C Method for preparing (Benzhydryloxyethylpiperidyl) aliphatic acid derivs. |
| 04/09/1997 | CN1034499C Olefine amide compound and its preparing method and use |
| 04/09/1997 | CN1034498C Octahydronaphthalene oxime derivs. for cholesterol biosynthesis inhibition, their preparation and use |
| 04/09/1997 | CN1034497C Process for preparation of aromatic amino-alcohol derivs. having antidiabetic and anti-obesity properties |